BULLETIN V2026-2570
GRAFTA NANOTECH CORP. ("GFTA")
[formerly WITTERING CAPITAL CORP. ("WITT.P")]
BULLETIN TYPE: Resume Trading, Qualifying Transaction-Completed/New Symbol, Private Placement-Non-Brokered, Name Change and Consolidation
BULLETIN DATE: August 7, 2026
TSX Venture Tier 2 Company
Resume Trading
The common shares of the Company have been halted from trading since October 27, 2025, pending completion of a Qualifying Transaction.
Effective at the opening, Tuesday, August 11, 2026, the common shares of Grafta Nanotech Corp. will commence trading on TSX Venture Exchange under the new symbol "GFTA".
Qualifying Transaction-Completed/New Symbol
TSX Venture Exchange has accepted for filing the Company's Qualifying Transaction described in its Filing Statement dated July 27, 2026. As a result, at the opening on Tuesday, August 11, 2026, the Company will no longer be considered a Capital Pool Company. The Qualifying Transaction includes the following:
The Qualifying Transaction involves the arm's length acquisition of Grafta Nanotech Inc. ("GNI") for consideration of 73,417,106 common shares at a deemed price of $0.20 per share, including 9,220,000 unit shares issued pursuant to a non-brokered subscription receipt private placement completed by GNI concurrent with the transaction. Each subscription receipt converts into one common share and one-half warrant with an exercise price of $0.40 for 18 months following closing. GNI paid aggregate cash finders fees of $41,265 and issued an aggregate of 206,325 non-transferable finder's warrants with an exercise price of $0.40 for 18 months.
35,892,740 common shares issued pursuant to the Qualifying Transaction are subject to a Tier 2 Escrow Agreement to be released over a 36-month period. 2,000,000 common shares (post-consolidation) are subject to a CPC Escrow Agreement to be released over an 18-month period.
The Exchange has been advised that the above transactions have been completed.
In addition, the Exchange has accepted for filing the following:
Private Placement-Non-Brokered
Financing Type: Non-Brokered Private Placement
Gross Proceeds: $300,000
Offering: 1,500,000 Listed Shares with 750,000 warrants (post-consolidation)
Offering Price: $0.20 per Listed Share (post-consolidation)
Warrant Exercise Terms: $0.40 per Listed Share (post-consolidation) for an 18-month period, subject to an acceleration right
Commissions in Securities: N/A
Disclosure: Refer to the company's news release dated August 7, 2026.
Name Change and Consolidation
Pursuant to a resolution passed by directors on July 3, 2026, the Company has consolidated its capital on a 2 old for 1 new basis. The name of the Company has also been changed as follows:
Effective at the opening Tuesday, August 11, 2026, the common shares of Grafta Nanotech Corp. will commence trading on TSX Venture Exchange, and the common shares of Wittering Capital Corp. will be delisted.
For further information, please refer to the Company's Filing Statement dated July 27, 2026, which is filed on SEDAR+ and press release dated August 7, 2026.
The Company is classified as a "All other miscellaneous chemical product manufacturing" company.
Capitalization: Unlimited shares with no par value of which
78,417,106 shares are issued and outstanding
Escrow: 37,892,740 common shares
Transfer Agent: Odyssey Trust Company
Symbol: GFTA (new)
CUSIP #: 38431Q 10 1 (new)
Company Contact: Mark Bentsen, Chief Executive Officer
Company Address: 121, 7155 - 57th St. SE, Calgary, Alberta, T2C 5W2
Company Phone Number: (833) 847-2382
Company Email Address: mbentsen@grafta.tech
_______________________________________
|
|
